scholarly journals The role of general practitioners in the follow up of type 1 diabetic patients with insulin pump therapy

2007 ◽  
Author(s):  
Alexander Kamaratos ◽  
Ioannis Lentzas ◽  
Marek Papathanasiou ◽  
Styliani Gerakari ◽  
Anargyros Mariolis ◽  
...  
Keyword(s):  
General Practitioners ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Diabetic Patients ◽  
Pump Therapy ◽  
Type 1 Diabetic Patients

Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up

2021 ◽  
Vol 68 (8) ◽  
pp. 567-572
Author(s):  
Nicolás Coronel-Restrepo ◽  
Víctor Manuel Blanco ◽  
Andres Palacio ◽  
Alex Ramírez-Rincón ◽  
Sebastián Arbeláez ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Real World ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Long Term Follow Up

scholarly journals Use of insulin pump therapy is associated with reduced hospital-days in the long-term: a real-world study of 48,756 pediatric patients with type 1 diabetes

2020 ◽  
Author(s):  
Marie Auzanneau ◽  
Beate Karges ◽  
Andreas Neu ◽  
Thomas Kapellen ◽  
Stefan A. Wudy ◽  
...  
Keyword(s):  
Insulin Pump ◽  
Injection Therapy ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Pediatric Diabetes ◽  
Acute Complications ◽  
Hospital Days

AbstractIn pediatric diabetes, insulin pump therapy is associated with less acute complications but inpatient pump education may lead to more hospital days. We investigated the number of hospital days associated with pump vs. injection therapy between 2009 and 2018 in 48,756 patients with type 1 diabetes < 20 years of age from the German Diabetes Prospective Follow-up Registry (DPV). Analyses were performed separately for hospitalizations at diagnosis (hierarchical linear models adjusted for sex, age, and migration), and for hospitalizations in the subsequent course of the disease (hierarchical Poisson models stratified by sex, age, migration, and therapy switch). At diagnosis, the length of hospital stay was longer with pump therapy than with injection therapy (mean estimate with 95% CI: 13.6 [13.3–13.9] days vs. 12.8 [12.5–13.1] days, P < 0.0001), whereas during the whole follow-up beyond diagnosis, the number of hospital days per person-year (/PY) was higher with injection therapy than with pump therapy (4.4 [4.1–4.8] vs. 3.9 [3.6–4.2] days/PY), especially for children under 5 years of age (4.9 [4.4–5.6] vs. 3.5 [3.1–3.9] days/PY).Conclusions: Even in countries with hospitalizations at diabetes diagnosis of longer duration, the use of pump therapy is associated with a reduced number of hospital days in the long-term. What is known:• In pediatric diabetes, insulin pump therapy is associated with better glycemic control and less acute complications compared with injection therapy.• However, pump therapy implies more costs and resources for education and management.What is new:• Even in countries where pump education is predominantly given in an inpatient setting, the use of pump therapy is associated with a reduced number of hospital days in the long-term.• Lower rates of hospitalization due to acute complications during the course of the disease counterbalance longer hospitalizations due to initial pump education

Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up

2020 ◽  
Author(s):  
Nicolás Coronel-Restrepo ◽  
Víctor Manuel Blanco ◽  
Andres Palacio ◽  
Alex Ramírez-Rincón ◽  
Sebastián Arbeláez ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Real World ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Long Term Follow Up

scholarly journals Insulin Requirements in Relation to Insulin Pump Indications in Type 1 Diabetes

2015 ◽  
Vol 7 (3) ◽  
pp. 259-263
Author(s):  
Gabriela GHIMPEŢEANU ◽  
Silvia Ş. IANCU ◽  
Gabriela ROMAN ◽  
Anca M. ALIONESCU
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Diabetic Patients ◽  
Pump Therapy ◽  
Daily Insulin ◽  
Insulin Requirements ◽  
High Hba1c ◽  
Basal Bolus

The purpose of the current research was to assess changes in daily insulin requirements in type 1 diabetic patients transitioning from multiple daily injections (MDI) of insulin to continuous subcutaneous insulin infusion (CSII) using an external insulin pump, according to clinical indications for changing therapy. The charts of 70 patients with type 1 diabetes (T1D) initiating insulin pump therapy were retrospectively reviewed before CSII and after optimization of glycaemic profile with CSII during hospital admission. Daily insulin doses, basal/bolus distributions, dose changes during treatment transition and glycaemic outcomes with MDI and optimized CSII according to insulin pump indications were evaluated. Daily insulin doses were not significantly different among indication groups, with both MDI and CSII; likewise, the overall daily distribution of basal/rapid insulin ratio was similar, around 40/60. With optimized CSII, significant differences were found only in basal/bolus distribution in patients initiating CSII for recurrent hypoglycemia, who had a significantly lower basal (6.4% lower) and a complementary higher bolus requirement, compared to patients initiating CSII for HbA1c ≥ 8.5%. At transition, basal insulin needs declined similarly in the high HbA1c and impractical/inflexible MDI groups by approximately 20%, and up to 30% in the recurrent hypoglycaemia group; bolus doses decreased by 20% when the indication was high HbA1c and by approximately 15% for the other indications. Glycaemic control was significantly improved only in patients initiating CSII for high HbA1c (≥8.5%). Insulin pump indication should be considered when starting T1D patients on CSII. These findings may support clinicians in decision making regarding insulin dose changes when initiating insulin pump therapy.

Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry

2021 ◽  
Vol 5 (1) ◽  
pp. 17-25
Author(s):  
Clemens Kamrath ◽  
Sascha R Tittel ◽  
Thomas M Kapellen ◽  
Thekla von dem Berge ◽  
Bettina Heidtmann ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Newly Diagnosed ◽  
Pump Therapy
Sign in / Sign up

Export Citation Format

Share Document